HRT Financial’s Strata Critical Medical Inc Warrants SRTAW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-14,420
Closed – – 4237
2026
Q1
$0 Buy
+14,420
New +$1.09K ﹤0.01% 3825
2024
Q1
– Sell
-10,569
Closed -$3K – 2348
2023
Q4
$3K Sell
10,569
-4,164
-28% -$1.19K ﹤0.01% 2149
2023
Q3
$3K Sell
14,733
-6,387
-30% -$3K ﹤0.01% 2215
2023
Q2
$14K Sell
21,120
-8,454
-29% -$3.78K ﹤0.01% 2131
2023
Q1
$14K Sell
29,574
-11,240
-28% -$6.94K ﹤0.01% 2217
2022
Q4
$20K Sell
40,814
-2,625
-6% -$1.68K ﹤0.01% 2176
2022
Q3
$27K Sell
43,439
-8,770
-17% -$7.43K ﹤0.01% 2471
2022
Q2
$33K Sell
52,209
-1,786
-3% -$2.71K ﹤0.01% 2554
2022
Q1
$109K Sell
53,995
-1,064
-2% -$1.67K ﹤0.01% 2637
2021
Q4
$122K Buy
55,059
+785
+1% +$1.92K ﹤0.01% 2702
2021
Q3
$155K Buy
54,274
+279
+0.5% +$583 ﹤0.01% 2774
2021
Q2
$147K Sell
53,995
-2,000
-4% -$4.36K ﹤0.01% 2494
2021
Q1
$139K Sell
55,995
-20,567
-27% -$75.2K ﹤0.01% 2400
2020
Q4
$187K Buy
76,562
+44,394
+138% +$58.3K ﹤0.01% 1511
2020
Q3
$39K Buy
+32,168
New +$34.8K ﹤0.01% 1715

HRT Financial's SRTAW Position: Q2 2026 in Review

HRT Financial sold out of Strata Critical Medical Inc Warrants (SRTAW) in Q2 2026, closing a stake of 14,420 shares.

HRT Financial first reported a position in SRTAW in Q3 2020 and held it in 15 quarters. The position peaked at $187K in Q4 2020. 0 funds tracked by Wall St. Rank hold SRTAW as of Q2 2026.

  • HRT Financial reported no remaining Strata Critical Medical Inc Warrants position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 14,420 Strata Critical Medical Inc Warrants shares in Q2 2026.
  • HRT Financial first reported a position in Strata Critical Medical Inc Warrants in Q3 2020 and held it in 15 quarters.
  • HRT Financial's Strata Critical Medical Inc Warrants position peaked at $187K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Strata Critical Medical Inc Warrants as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.